- $9.34bn
- $12.90bn
- $1.12bn
NYSE ORDER IMBALANCE 61654.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 77546.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 101369.0 SHARES ON BUY SIDE
CubeSmart reports results for the quarter ended in September - Earnings Summary
Brief: Cubesmart Reports Third Quarter 2022 Results
Brief: Cubesmart - On October 25, Board Of Company Increased Size Of Board To Nine Members
CubeSmart expected to post earnings of 28cents a share - Earnings Preview
NYSE ORDER IMBALANCE 82665.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 53714.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 195056.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 65663.0 SHARES ON SELL SIDE
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Coupa Software, Docusign
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Coupa Software, Docusign
NYSE ORDER IMBALANCE 56318.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 52170.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 117742.0 SHARES ON BUY SIDE
Brief: Cubesmart Q2 Adjusted FFO Per Share $0.62
NYSE ORDER IMBALANCE 102393.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 50984.0 SHARES ON BUY SIDE